Optibrium expands 3D drugs offering with BioPharmics acquisition

[ad_1] BioPharmics has developed a series of algorithms and software for 3D ligand-based and structure-based computational drug design, including software for 2D to 3D ligand conversion and conformer generation (ForceGen),…